The Krasno-Ivy nitroglycerin-flicker fusion test was carried out in normal persons, and in patients with arterial hypertension and/or coronary disease. A positive test was obtained more often in patients with cardiovascular abnormalities than in normal individuals. In the former group the frequency of negative results and the inconstancy of response to multiple tests indicate the unreliability of this procedure for "the early detection of heart disease tendency." No correlation could be demonstrated between the results of the flicker fusion test, the Master twvo step or the cold pressor test. The evidence does not support the, alleged clinical usefulness of the nitroglycerinflicker fusion test.
T HE flicker fusioIi threshold (FFT) refers to that frequency of successive flashes of light at which the light stimulus appears to be continuous in intensity or free from flicker. It has been alleged that the flicker fusion threshold of a normal subject is rarely less than 2400 flashes per minute or 40 per second as measured by the flicker photometer of Krasno and I-vy.' Ill other words, successive flashes below this critical level should appeal as a flickering light wvheln observed b)y a normal individual according to a prescribeel technic. These authors, furthermore, havte reported that the flicker fusion threshold is lowler than normal or impaired ill patients with a definite hypertension or anemia and improves when these conditions respond to therapeutic ineasures. They have devised a nitroglycerin-flicker test which involves the (letermination of the flicker fusion threshold before and at twvo minute intervals after the sublingual administration of nitroglycerin (0.4 mg.). They report that nitroglycerin impaired the threshold ill normal subjects; whereas, in almost all patients with hypertension or corotnary disease under their observation, nitroglycerin improved the flicker fusion threshold. Krasno and Ivy illterpret these observations as follows: (1) Im-From the Cardiovascular Research Unit, Department of Medicine, U. S. Marine Hospital, Staten Island, N. Y., as a Joint Project with the National Heart Institute, U. S. Public Health Service, Washington, D. C. 359 pairmeint of the flicker fusion threshold in normal subjects after nitroglycerin is due to ,vasodilation and resultant passive hyperemia of the visual mechanism. (2) Improvement of the threshold after nitroglycerin is evidence of the relief of vasospasm and conisequent active hyperemia. Iii their opinion the nitroglyceriiiflicker test may prove to be a valuable aid in (a) the detection of anginia pectoris and coronary occlusion where the evidence is equivocal, (b) the ideittification of potential candidates for hypertension and coronary disease, and (c) the evaluation of vasodilator properties of various drugs.
The value of any test capable of detecting latent coronary disease without subjecting the latieiit to the danger of stress is clearly appareiit. Inasmuch as the Master two step test2 has proved of assistance in the diagnosis of oroiiarv insufficiency iii cases in which the history and resting electrocardiogram are equivocal, it seemed worth while to compare the results of the flicker fusion threshold test and the iMaster two step test in patients with kinown coronary disease. Similarly, comparison could be made between the flicker fusion threshold and the cold pressor test,3 since the latter has also been advocated as a means of identifying potential hypertenisives among the "normal" population.
Obviously, if any test is to be accepted as a diagnostic procedure ill the detection of potential or early cardiovascular disease it should Circulation, Volume I V, September, 1951 demonstrate a high degree of specificity when comparison is made between normal persons and subjects with clinically advanced lesions.
MATERIAL Thirty-one normal men who served as control subjects were studied by means of the flicker photometer of Krasno and Ivv. In each instance there was no history of previous cardiovascular disease.
Physical examination, x-ray study of the chest for heart size and electrocarliographic studies in each of these individuals disclosed no abnormal findings. Their ages ranged from 39 to 64 years. All of the patients in this group had been hospitalized for causes completely unrelated to the cardiovascular system. Tests were performed upon these subjects during convalescence shortly before discharge from the hospital. Seventy-eight nitroglycerin flicker tests were obtained in these 31 patients.
Seventy-six patients with hypertensive and/or arteriosclerotic heart disease served as test subjects for this study. All but 2 of these patients were of the male sex. The ages ranged from 19 to 75 years. Of the 76 patients, 22 had advanced hypertensive disease with organic changes, 4 had chronic glomerulonephritis, one had coarctation of the aorta, 2 had transient hypertension and 9 patients showed no signs other than sustained elevation of arterial blood pressure (above 140/90). Thirty-eight patients had clinical and electrocardiographic evidence of arteriosclerotic heart disease. In this group, 16 of 19 patients studied by means of the AMaster two step test showed a consistently positive response. Fourteen of the 38 patients had sustained previous myocardial infarction.
All of the test subjects had been hospitalized for treatment of their cardiovascular abnormalities. Two hundred and fifty-seven nitroglycerin-flicker tests were performed upon these 76 patients. In addition the i\Iaster test was obtained in 41 and the cold pressor test in 28 of these subjects.
METHOD
All tests were performed in the same room which was illuminated by means of overhead indirect lighting. The outside light was partially excluded by means of ordinary window shades. The patients were not permitted to smoke for at least six hours, to drink alcohol for at least 24 hours, or to receive vasodilator medication for at least 72 hours prior to the performance of the flicker test. No one was subjected to more than one test each day.
Method I. The patient was seated upon a table with his legs extended; the flicker photometer was placed upon a platform at eve level a distance of 5 feet from the patient. A blood pressure cuff was attached to the patient's arm so that blood pressure determinations could be made at one, three, and five minute intervals after the administration of the nitroglycerin. The test was explained to the pltient and the flicker fusion threshold determined as originally described by Krasno and Ivy.1'4 The rate of flicker was set at 3000 flashes per minute and was decreased at a slow, even rate until the patient detected flicker. The light was then turned off and the patient instructed to look away to avoid eye fatigue. The procedure was reepeated in similar manner except that the point of beginning was selecte(l at 300 flashes per minute above the previous fusion threshold of the patient. When two sets of three successive readings were the same, this value weas recorded as the patient's fusion frequency threshold. If three successive identical readings could not be obtained within six trials, the test was again explained to the patient and a new attempt made after a rest of a few minutes. The patient was then given 0.4 mg. nitroglycerin sublingually and the fusion threshold determined at two minute intervals for six minutes. In the event that a change of less than 60 flashes per minute -as obtained, the pa tient was given another nitroglycerin tablet if he could tolerate it and the fusion frequency threshold determined again at two minute intervals. Sixtyseven tests were performe(l upon 28 patients with cardiovascular disease by this technic. Method II. This method differed from the above in that the patient was seated in a more natural position in a chair so l)lace(l that lie was 5 feet from the flickerlphotometer. The patients were instru(ted not to look away from the light source between reaclings until three successive identical results were ohtained. This change was made at the suggestion of Dr. Krasno who felt that the altered technic might improve the patient's power of concentration.9 For similar and other reasons, blood pressure determinations were not carried out as in method I. Seventyeight tests in 31 normal patients and 138 tests in 27 patients with cardiovascular disease were p)erformed by this method. Method III. The technic was again changed to conform with new instructions supplie(l by Dr. Krasno.5'9 Instead of the control dial being turned at a slow, even rate of speed, it was mnoved at a more moderate, even rate until the dial applroa(hed within 100 flashes per minute of the approximate baseline. The dial w-as then slowed to a creeping rate of speed "to permit the patient to attain his maximum fusion threshold." Otherwise, method III is the same as method II. Fifty-two tests were performed on 21 patients with cardiox-ascular disease byr this technic.
RESULTS
Inasmuch as the results of the nitroglycerin flicker test were similar with each of the three technics, both in the same patients and statis-tically, no separation of data appeared indicated.
Of 78 tests performed on 31 normal subjects, 16 were positive, 35 negative and 27 equivocal (no change following nitroglycerin). Thus 21 per cent of the tests in the normal group were positive, 45 per cent were negative and 34 per 0  2  3  3  0  2  2  3  1  3  2  3   0   1  1  3  0  3  0  2  1  3  0  2   1  2  2  3  0  3  3  3  2  3  1  2  2  3  1  1  1  3  0  3  0  2   0  3  1  3  0  3  0  3   0   1  1  2  0  2  2  3 cent were equivocal. Since the 16 positive tests were obtained in 11 of the 31 normal subjects, it is apparent that approximately one out of 3 in the normal group gave an abnormal response to the nitroglycerin flicker test (tables 1 and 2). Of 28 normal subjects upon whom more than one test was performed, 7 showed both positive and negative responses and 14 gave one or more indeterminate results in addition to positive and/or negative responses. In 3 subjects upon whom seven tests were per-formed, all of the responses were equivocal. From table 1 it can be seen that the average age of those giving one or more positive tests is significantly greater than that of the subjects who showed only negative response. Of 130 tests performed on 38 hypertensive patients, 41 were positive, 69 negative and 20 equivocal. Thus 32 per cent of the tests performed on these hypertensive subjects were positive, 53 per cent were negative and 15 per cent were equivocal. Inasmuch as the 41 positive tests were obtained in 24 of the 38 patients, it may be stated that approximately 2 out of 3 of the hypertensive patients showed one or more positive responses. This finding is in distinct contrast with that observed in the normal group in which one or more positive tests were obtained in approximately one out of every 3 patients studied. In the 27 hypertensive patients in whom more than one nitroglycerinflicker test was performed, 15 showed both negative and positive responses. In this latter group of 15 patients, 54 tests were negative and 28 positive. Moreover, in the 27 patients in whom more than one test was obtained, only 3 showed a consistently positive response whereas 5 patients of this group revealed consistently negative responses. If the results obtained in the 38 hypertensive patients are analyzed according to the predominance of positive or negative tests in each of the patients, it is seen that 10 could be classified as "positive" and 18 as "negative" (table 3) . These findings appear to indicate that a positive response to the nitroglycerin-flicker test is more commonly encountered in hypertensive than in "normal" subjects. Repeated performance of the test in patients with arterial hypertension will almost invariably result in one or more positive respoi ever, as many tensive and coronary groups the great frequency of negative tests indicates that one or a single hypertensive patient even a few such responses in any given patient tain one positive response. The is without diagnostic significance. y of negative responses in the Forty-four patients in the total series were ;roup therefore indicates a rela-tested by means of the Master two step test2 rree of specificity of this test. and/or the cold pressor test3 (table 5). In 19 hypertensive patients upon whom the cold pressor test was performed, 12 were found to 
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Neg. 363 1 The cold pressor test, performed on 11 patients in the coronary disease group, showed 6 of the subjects to be hyperreactors. Three of the 6 hyperreactors failed to show either a positive response or predominantly positive responses (if more than one test was performed) to the flicker test. It seems apparent, therefore, that no correlation exists between the results of the nitroglycerin-flicker fusion test and the cold pressor test in subjects with cardiovascular disease.
Thirty-three of 41 patients studied showed a consistently positive response to the Master two step test. Of these 33 patients, 22 failed to show either a positive response or more positive than negative responses (wshen multiple tests were performed) to the flicker test. Of 92 flicker tests performed on these 33 patients who showed a positive response to the Master two step test, 56 were negative and only 36 were positive. Thus, while a series of flicker tests is more likely to show one or more positive responses in patients with coronary disease than in normal persons, the method obviously lacks the specificity of the resting and exercise electrocardiograms in the diagnosis of arteriosclerotic heart disease.
DIscussIoN
Our observations of the response to the nitroglycerin-flicker test in 31 normal subjects and 76 patients with cardiovascular disease indicate that a positive response is more likely to be encountered in the latter group when either single or multiple tests are performed. While this phenomenon appears to be of interest, it would seem of little value in the diagnosis of angina pectoris, coronary occlusion, or incipient hypertension when the evidence is equivocal. Our data show that a single negative test or even multiple negative tests are not uncommonly encountered in the presence of advanced cardiovascular disease. It is not unusual for patients who present clinical evidence of heart disease, abnormal resting electrocardiograms and/or a positive 1\aster two step test to show one or more consecutive negative responses to the flicker test. Such negative responses are certainly a frequent occurrence in patients with arterial hypertension regardless of the severity of the disease. The fact that there is a greater frequency of negative tests in patients with hypertension than in those with cardiovascular abnormalities without hypertension seems to challenge the basic hypothesis that the nitroglyceriin-flicker fusion test is capable of revealing vasospasm.
From these considerations it is evident that a negative test is of no significance. Moreover, it is unknown whether or not a positive test can be accepted as evidence of existent or incipient cardiovascular derangement. Twentyone per cent of the tests performed upon patients in our normal group were positive. Before any significance could be attributed to such positive response in normal subjects it would have to be shown by prolonged follow-up studies that a positive test is a heralding sign of cardiovascular disease.
It is possible that the flicker test will have as little value in the diagnosis of abnormalities of the cardiovascular system as the cold pressor test has had in the detection of latent or incipient hypertension. Thus, although the cold pressor test in hypertensive subjects shows an incidence of hyperreaction amounting to approximately 95 per cent, no compelling evidence has been advanced in the 15 years since its introduction to Awarrant acceptance of the hypothesis that a positive cold pressor test in an apparently normal subject indicates potential hypertension. On the contrary, one of us has shown that hyperreaction is in some Away related to the phenomenon of aging, and is unrelated to a positive family history of hypertensive disease.6 In similar maimer a positive flicker test may be more common in the presence of cardiovascular disease and yet exist in apparently normal subjects in whom such abnormalities are neither existent nor threatening.
Comparison of results of the flicker fusion test with those of cold pressor and Master tests has not confirmed the value of the first as a diagnostic aid. 'No significant correlation was observed between the findings of the Master test and the flicker test, or between the cold pressor test and the flicker test. The inconsistency of response to the nitroglycerinflicker fusion test even ill the presence of advanced cardiovascular disease, indicates that this technic would be completely unreliable for the evaluation of the vasodilator properties of various drugs.
It is our conclusion that Krasno and Ivy have reported an interesting phenomenon which is worthy of further research investigation. We believe, however, that representation of the flicker fusion photometer to the medical profession and laity as an instrument "for the early detection of heart disease tendency"8 is both unwarranted and unwise. It should be obvious that in the light of present knowledge incalculable harm can result from conclusions derived from the use of this instrument. Certainly, no justification exists at this time for the employment of the photometer in general practice because of its lack of scientific foundation and its great potentialities for inducing cardiac neuroses. Moreover, it should be recognized that the procedure is not completely innocuous. Of 107 patients tested, 8 showed circulatory collapse as a direct result of the prescribed sublingual administration of nitroglycerin (0.4 mg.).
SUMMARY
The nitroglycerin-flicker fusion test was performed on 107 subjects of which 31 were normal persons and 76 were patients with cardiovascular disease. In the latter group, 38 had arterial hypertension and 38 arteriosclerotic heart disease. A positive flicker test was more commonly encountered among patients with disease of the cardiovascular system than among normal subjects. The frequency of a single negative test or even multiple negative tests, however, in patients with well established abnormalities of the heart or blood vessels clearly indicates the lack of specificity of this test for the diagnosis of such disease. These findings open to question the basic hypothesis that the test is a sensitive indicator of underlying vasospasm and suggest that other mechanisms may be responsible for a positive test.
The inconsistency of response even in the presence of well established cardiovascular disease renders the test unreliable for the evaluation of vasodilator properties of various drugs.
No correlation was found between the results of the nitroglycerin-flicker test and those of the Master and cold pressor tests respectively. The comparison of the three methods throws doubt upon the significance of a positive response to the flicker test. Follow-up studies over a period of years wN-ill be necessary to determine the meaning of a positive response in normal subjects. Until such information becomes available, the flicker fusion photometer should be made a research instrument exclusiv ely. The potential dangers from its wvide-spread employment "for the early detection of heart disease tenidenicy'" should be recognized and prevented.
